Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
Create a narrative
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
57.7% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
26
users have liked this narrative
7
users have commented on this narrative
62
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
28.0% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
35
users have liked this narrative
6
users have commented on this narrative
93
users have followed this narrative
Updated
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
20.6% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
14
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Y-mAbs Therapeutics
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
Pipeline Developments And Radiopharmaceutical Advances Will Extend Global Reach
Key Takeaways Stronger market adoption of DANYELZA and international expansion are expected to drive recurring revenue and broaden the patient base. Advancements in antibody engineering and rare oncology pipeline will support new product launches and profitable long-term growth.
View narrative
US$8.60
FV
1.0% undervalued
intrinsic discount
8.92%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
Updated
narrative
Solid Power
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Electrolyte Center And Auto Partnerships Will Expand Market Reach
Key Takeaways Strategic partnerships with industry leaders and expanded R&D activities aim to boost market penetration and accelerate technology adoption. Focus on high-margin electrolyte development and continuous manufacturing seeks to improve margins and capture solid-state battery market share.
View narrative
US$2.50
FV
n/a
intrinsic discount
16.99%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
26
users have followed this narrative
Updated
narrative
Hagerty
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Cloud-Based Insurance Will Expand Enthusiast And Collector Markets
Key Takeaways Expansion into modern vehicle insurance and digital infrastructure enhances market reach and operational efficiency, supporting sustained revenue and long-term margin growth. Growing wealth and international expansion, combined with strategic partnerships and recurring revenue streams, drive demand and earnings stability across Hagerty’s ecosystem.
View narrative
US$11.00
FV
3.2% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
10 days ago
author updated this narrative
Six Flags Entertainment
AN
AnalystConsensusTarget
Consensus Narrative from 13 Analysts
Revamped Attractions And Digital Integration Will Boost Demand
Key Takeaways Enhanced digital platforms, premium offerings, and new attractions are driving higher guest spending, operational efficiency, and more predictable recurring revenue. The Cedar Fair merger and rigorous cost discipline are structurally lowering the cost base, improving margins, and accelerating debt reduction through stronger free cash flow.
View narrative
US$35.31
FV
n/a
intrinsic discount
5.29%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
Updated
narrative
Skyworks Solutions
AN
AnalystLowTarget
Consensus Narrative from 19 Analysts
Maturing Smartphones And Apple Dependence Will Cripple Value
Key Takeaways Heavy dependence on mobile and a single large customer exposes Skyworks to revenue volatility and long-term growth challenges. Rising competition, cost pressures, and lagging R&D investment threaten future profitability and competitive positioning.
View narrative
US$52.43
FV
35.6% overvalued
intrinsic discount
-1.51%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
10 days ago
author updated this narrative
Western Digital
AN
AnalystLowTarget
Consensus Narrative from 21 Analysts
Shrinking HDD Market And Asian Rivalry Will Weaken Outlook
Key Takeaways Ongoing market shifts toward advanced storage and intensifying competition threaten Western Digital's revenues, margins, and long-term growth prospects. Structural industry changes, heavy debt, and slow innovation increase risks to reliable earnings and future shareholder returns.
View narrative
US$42.07
FV
78.2% overvalued
intrinsic discount
-12.26%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
10 days ago
author updated this narrative
Molina Healthcare
AN
AnalystLowTarget
Consensus Narrative from 14 Analysts
Rising Healthcare Costs And Policy Risks Will Erode Margins
Key Takeaways Persistent rises in medical costs and tightening government policies are set to pressure profitability and weaken Molina's core business stability. Dependence on government contracts and challenges in digital innovation pose risks of membership loss and revenue decline amid increasing competition.
View narrative
US$153.00
FV
2.5% overvalued
intrinsic discount
5.42%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
10 days ago
author updated this narrative
PTC
AN
AnalystLowTarget
Consensus Narrative from 19 Analysts
Geopolitical Tensions And Open-Source Trends Will Erode Recurring Revenue
Key Takeaways Delayed software investments and reliance on volatile industries expose PTC to unpredictable revenue and hinder growth opportunities. Rising competition from open-source adoption and industry commoditization threatens pricing power, market share, and long-term profitability.
View narrative
US$160.00
FV
28.4% overvalued
intrinsic discount
9.70%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
10 days ago
author updated this narrative
Emerson Electric
AN
AnalystLowTarget
Consensus Narrative from 27 Analysts
Rising Tariff Pressures And Digital Challenges Will Squeeze Margins
Key Takeaways Heightened global protectionism, integration challenges, and shifting customer preferences toward digital automation threaten Emerson's margins, revenue stability, and earnings momentum. Growing competition from low-cost and open-source providers, alongside weak industrial demand in key regions, undermines pricing power and long-term growth prospects.
View narrative
US$109.01
FV
21.8% overvalued
intrinsic discount
4.53%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
10 days ago
author updated this narrative
Value any company in seconds
Popular companies